FANTINI, FLAVIO
 Distribuzione geografica
Continente #
EU - Europa 4.446
NA - Nord America 3.246
AS - Asia 2.595
SA - Sud America 230
AF - Africa 74
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.596
Nazione #
US - Stati Uniti d'America 3.134
GB - Regno Unito 1.324
CN - Cina 1.066
SG - Singapore 694
IT - Italia 627
DE - Germania 595
SE - Svezia 419
FR - Francia 384
RU - Federazione Russa 298
UA - Ucraina 290
IN - India 219
HK - Hong Kong 180
TR - Turchia 148
EU - Europa 136
IE - Irlanda 134
BR - Brasile 130
KR - Corea 128
NL - Olanda 107
CA - Canada 95
FI - Finlandia 92
CO - Colombia 68
GR - Grecia 63
VN - Vietnam 56
CI - Costa d'Avorio 39
PL - Polonia 30
JP - Giappone 24
DK - Danimarca 20
BE - Belgio 15
UZ - Uzbekistan 13
RO - Romania 11
CZ - Repubblica Ceca 10
ID - Indonesia 10
AR - Argentina 8
EC - Ecuador 7
IQ - Iraq 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
VE - Venezuela 6
ZA - Sudafrica 6
EG - Egitto 5
ES - Italia 5
MX - Messico 5
MY - Malesia 5
BD - Bangladesh 4
SA - Arabia Saudita 4
TN - Tunisia 4
UY - Uruguay 4
BG - Bulgaria 3
BO - Bolivia 3
BS - Bahamas 3
BY - Bielorussia 3
HR - Croazia 3
IL - Israele 3
NG - Nigeria 3
TW - Taiwan 3
AL - Albania 2
AT - Austria 2
BA - Bosnia-Erzegovina 2
CH - Svizzera 2
CY - Cipro 2
GA - Gabon 2
KE - Kenya 2
KW - Kuwait 2
MA - Marocco 2
MW - Malawi 2
PE - Perù 2
PY - Paraguay 2
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CR - Costa Rica 1
CV - Capo Verde 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
GL - Groenlandia 1
GM - Gambi 1
GN - Guinea 1
GT - Guatemala 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
Totale 10.723
Città #
Southend 1.180
Singapore 362
Chandler 328
Ashburn 302
Beijing 285
Jacksonville 264
Santa Clara 177
Hong Kong 166
Milan 161
Princeton 161
Seattle 146
Dublin 132
Wilmington 126
Bengaluru 122
Redmond 116
Mountain View 111
Frankfurt am Main 108
Ann Arbor 102
Serra 97
Toronto 87
Nanjing 83
Council Bluffs 80
Los Angeles 77
Bogotá 68
Dallas 67
Dearborn 67
Sakarya 67
Andover 66
Athens 62
Somerville 60
Boardman 56
Shanghai 56
Woodbridge 55
Shenyang 41
Abidjan 39
Houston 35
Des Moines 33
Jinan 33
Grafing 32
Berlin 31
Buffalo 28
Moscow 28
Nanchang 27
Ho Chi Minh City 25
Changsha 24
Hebei 24
Warsaw 23
Bitonto 22
Cangzhou 22
Fairfield 22
Hefei 21
Guangzhou 20
Helsinki 20
Rome 18
Kunming 16
Munich 16
Saint Petersburg 15
Columbus 14
Fuzhou 14
Scranton 14
Tianjin 14
Verona 14
Kiez 13
Quanzhou 13
São Paulo 13
Tokyo 13
Brussels 12
Falls Church 12
Nürnberg 12
Redwood City 12
Roxbury 12
Taiyuan 12
The Dalles 12
A Shan 11
Auburn Hills 11
Bühl 11
Fremont 11
Hangzhou 11
Kent 10
Lanzhou 10
Ningbo 10
Norwalk 10
Shenzhen 10
Zhengzhou 10
Hanover 9
Pune 9
Brno 8
Dong Ket 8
New York 8
San Diego 8
Haikou 7
Jiaxing 7
Roubaix 7
Sunnyvale 7
Taizhou 7
Florence 6
Fort Worth 6
Itapetininga 6
Jakarta 6
Phoenix 6
Totale 6.448
Nome #
Anticorpi anti-peptide citrullinato ciclico in pazienti con artropatia sclerodermica 339
Activation of inflammation, coagulation and fibrinolysis in patients with Rheumatoid Arthritis : inhibition by Tumor Necrosis Factor alpha blockade 310
Cellule endoteliali circolanti quale marker diretto di danno endoteliale in corso di sclerosi sistemica 273
Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis : effects of tumor necrosis factor-alpha blockade 259
Un nuovo algoritmo prognostico basato su parametri capillaroscopici e autoanticorpali per identificare i soggetti con fenomeno di Raynaud a rischio di sviluppare sclerosi sistemica 258
Ruolo della videocapillaroscopia periungueale in pazienti con dermato/polimiosite idiopatica dell’adulto e infantile 256
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 254
Long-Term Evaluation (Efficacy and Safety) of Infliximab in the Treatment of Persistently Active Juvenile Idiopathic Arthritis (JIA), Refractory to Standard Treatments 229
Progenitori delle cellule endoteliali di origine midollare in corso di sclerosi sistemica: possibile ruolo nell’angiogenesi=Endothelial progenitor cells in systemic sclerosis: their possible role in angiogenesis 209
Comparative analysis of different indices of hand disability in systemic sclerosis 209
Trattamento con un dispositivo ortodontico per l’impegno temporomandibolare nell’artrite idiopatica giovanile. Osservazioni su 72 casi 201
Valutazione del dannno anatomico e funzionale della mano nei pazienti con sclerosi sistemica 200
Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. 199
Haemostatic and inflammatory biomarkers in patients with rheumatoid arthritis : effect of tumor necrosis factor alpha blockade 197
Bronchus-associated lymphoid tissue lymphoma in a patient with primary Sjögren's syndrome 193
Haemostatic and inflammatory biomarkers in patients with active Rheumatoid Arthritis : effects of Tumor Necrosis Factor alpha blockade 188
IL1 and TNF gene polymorphisms in patients with juvenile idiopathic arthritis treated with TNF inhibitors 186
Effetto della terapia con infliximab sui marcatori di infiammazione, coagulazione e fibrinolisi nell’artrite reumatoide 184
Temporomandibular joint involvement in juvenile idiopathic arthritis : treatment with an orthodontic appliance 180
Prognostic model based on nailfold capillaroscopy for identifying Raynaud's phenomenon patients at high risk for the development of a scleroderma spectrum disorder : PRINCE (prognostic index for nailfold capillaroscopic examination) 179
Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy 178
Systemic sclerosis, capillary leak syndrome and nasopharyngeal carcinoma : an unusual association or paraneoplastic manifestations? 178
Anti-tumor necrosis factor alpha therapy normalizes fibrinolysis impairment in patients with active rheumatoid arthritis 174
Nailfold capillaroscopic report : qualitative and quantitative methods 173
Effect of tumor necrosis factor alpha blockade on inflammatory and haemostatic biomarkers in patients with rheumatoid arthritis 172
Evaluation of nailfold videocapillaroscopic abnormalities in patients with systemic lupus erythematosus 171
Utility and reliability of different capillaroscopic measures for the identification of secondary Raynaud’s phenomenon 170
Diagnostic validity in detecting different capillaroscopic patterns by qualitative versus quantitative scoring methods 167
Feasibility of different capillaroscopic measures for identifying nailfold microvascular alterations 163
Reduction of haemostatic and inflammatory biomarkers by tumor necrosis factor-alpha bockade in patients with rheumatoid arthritis 163
A novel prognostic rule-based scheme for identifying Raynaud’s phenomenon patients at high risk for the development of systemic sclerosis using capillaroscopy and autoantibodies 163
Bilateral vocal fold immobility in a patient with overlap syndrome rheumatoid arthritis/systemic sclerosis 158
Efficacy of a second TNFAlpha blocker when the first one failed in patients with juvenile idiopathic arthritis (JIA) treated with Infliximab, Etanercept and Adalimubab 156
Juvenile idiopathic arthritis in adulthood in a tertiary reference centre 155
Skeletal mineralization in a prepubertal female population affected by juvenile idiopathic arthritis 153
Reliability and validity of the Italian version of the hand functional disability scale in patients with systemic sclerosis 151
PRINCE: prognostic index for nailfold capillaroscopic examination for identifying raynaud's phenomenon at high risk of developing into a scleroderma spectrum disorder 149
Simultaneous ultrasonography and arthroscopy for the study of the joint environment: indications and limits 147
Treatment of active rheumatoid arthritis (RA) with combination therapy by adding leflunomide (LEF) in patients with an inadeguate response to methotrexate (mtx) 146
Capillaroscopic observations in childhood rheumatic diseases and healthy controls 146
Chronic Recurrent Multifocal Osteomyelitis (CRMO) : four cases treated with Aminobisphosphonate (Pamidronate) 146
CHARACTERIZATION OF OSTEOCORTICAL-PERIOSTEAL LAYERS BY HIGH-RESOLUTION SONOGRAPHY USING A DOPPLER TECHNIQUE IN PAGET'S DISEASE OF BONE 146
The effect of anti-TNF therapy on uveitis associated with juvenile idiopathic arthritis : the ten tear experience of our centre 145
A Comparison of Response Criteria in Patients with Juvenile Idiopathic Arthritis Treated with Methotrexate And/or Anti-Tnfα Agents 143
Hand impairement in systemic sclerosis : a comparative analysis of different functional indices in a cross-sectional study 141
Pregnancy outcome in women with inherited/acquired thrombophilia 140
Monitoring therapeutic response by power doppler technique (PWD) of osteocortical-periosteal layers in a series of 31 patients with Paget's disease in standard treatment 138
Distinct immune profiles characterize patients with diffuse or limited systemic sclerosis 137
Side Effects of Anti-Tnfα Therapy in Jia, in an Open Monocentric Prospective Study of 151 Patients 136
Assessment of negative prognostic factors in patients affected by systemic sclerosis with cardiac involvement. A retrospective study 135
Anti-Cyclic Citrullinated Peptide Antibodies in Juvenile Idiopathic Arthritis (jia). A Monocentric Cross-Sectional Study 135
Scleroderma-like pattern in patients with systemic lupus erythematosus (SLE): a red flag for overlap syndrome SLE/systemic sclerosis? 131
Evaluation of cognitive dysfunction in patients with juvenile onset SLE 130
Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis : results of an open-label prospective study 129
Anakinra in systemic juvenile idiopathic arthritis (SOJIA) non responsive to anti-TNF 129
Primary antiphospolipid syndrome associated with small aorta syndrome: a case report. 124
Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients 123
The efficacy and cost effectiveness of iloprost in the treatment of systemic sclerosis: a comparative analysis 121
Valutazione dei fattori prognostici negativi in pazienti affetti da sclerosi sistemica con coinvolgimento cardiaco: studio retrospettivo 121
Effectiveness and safety of leflunomide in the clinical practice. A different experience 119
Evaluation by dual-photon absorptiometry of bone mineral loss in rheumatic children on long-term treatment with corticosteroids 119
About the difficulty in interpreting ultrasonographic images of temporomandibular joint 118
Disfunzione cognitiva nel LES ad insorgenza giovanile 118
Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience 117
Treatment of Severe Systemic Sclerosis (SSC) with autologous Haematopoietic Stem Cell Transplantation (HSCT): description of two cases 116
Effectiveness and safety of leflunomide in the clinical practice : a different experience 113
Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis 106
Ruolo delle chemochine nella patogenesi della sinovite cronica in corso di artrite reumatoide [Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis] 57
Totale 11.269
Categoria #
all - tutte 29.100
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.100


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021842 0 0 0 0 77 88 103 51 159 61 255 48
2021/2022617 62 13 12 7 25 19 91 32 110 59 62 125
2022/20231.042 149 97 72 176 111 221 16 55 98 6 31 10
2023/2024628 11 51 43 45 183 81 16 47 9 13 62 67
2024/20251.650 51 204 19 209 183 59 54 145 32 92 113 489
2025/20261.097 353 132 275 225 112 0 0 0 0 0 0 0
Totale 11.269